Paul K. Wotton
2009
In 2009, Paul K. Wotton earned a total compensation of $636K as Chief Executive Officer at Antares Pharma, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $140,000 |
|---|---|
| Option Awards | $91,238 |
| Salary | $337,000 |
| Stock Awards | $59,500 |
| Other | $8,250 |
| Total | $635,988 |
Wotton received $337K in salary, accounting for 53% of the total pay in 2009.
Wotton also received $140K in non-equity incentive plan, $91.2K in option awards, $59.5K in stock awards and $8.3K in other compensation.
Rankings
In 2009, Paul K. Wotton's compensation ranked 6,015th out of 9,885 executives tracked by ExecPay. In other words, Wotton earned more than 39.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,015 out of 9,885 | 39th |
Division Manufacturing | 2,176 out of 3,690 | 41st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 324 out of 602 | 46th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 168 out of 326 | 49th |
Industry Surgical and Medical Instruments and Apparatus | 110 out of 212 | 48th |
Source: SEC filing on April 13, 2012.
Wotton's colleagues
We found three more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2009.